thalidomide has been researched along with Central Nervous System Origin Vertigo in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Juliusson, G | 1 |
| Celsing, F | 1 |
| Turesson, I | 1 |
| Lenhoff, S | 1 |
| Adriansson, M | 1 |
| Malm, C | 1 |
2 other studies available for thalidomide and Central Nervous System Origin Vertigo
| Article | Year |
|---|---|
[Potential side effects of thalidomide].
Topics: Constipation; Disorders of Excessive Somnolence; Drug Eruptions; Humans; Immunosuppressive Agents; L | 2006 |
Frequent good partial remissions from thalidomide including best response ever in patients with advanced refractory and relapsed myeloma.
Topics: Adult; Aged; Angiogenesis Inhibitors; Bence Jones Protein; Drug Administration Schedule; Female; Hum | 2000 |